Abstract:Cancer cell metabolism is quite different from normal cells. Targeting cancer metabolism and untuning the tumor metabolic machine has emerged as a promising strategy for cancer therapy. We have developed a multi-functional Re-dca conjugate (Re-dca 2) by conjugating the metabolic modulator dichloroacetate (DCA) to mitochondria-targeted rhenium(I) complex, allowing its efficient penetration into cancer cells and selective accumulation in mitochondria, thus achieving the cancer cell metabolism reversal from glycolysis to glucose oxidation at pharmacologically relevant DCA doses. Mechanism studies confirm the inhibition effect of Re-dca 2 on the activity of pyruvate dehydrogenase kinase (PDK) and capture the metabolic reversal window in Re-dca 2 treated NCI-1229 cells at the early stage of drug treatment, resulting in selective killing of malignant cells cocultured with normal cells, significant inhibition of cancer cell metastasis and invasion, as well as excellent anti-angiogenesis activities in zebrafish embryos. By comparison, DCA-free Re(I) analogue is also investigated under the same conditions. Although this analogue also exhibits cytotoxicity due to the Re(I) core, metabolic reversal is not induced by this analogue and its anti-metastasis activity is much lower than Re-dca 2, indicating the synergistic effect of Re(I) core and DCA moiety on cancer therapy. In vivo anti-cancer investigations also indicate that the mitochondria-targeted Re-dca 2 can effectively inhibit the tumor growth without affecting the body weight of nude mice, and the therapeutic effect is much better than the DCA-free Re(I) analogue 2a. Simultaneously, the O2-sensitive phosphorescent lifetimes of Re-dca 2 can be utilized for PLIM imaging of intracellular oxygen consumption, thus reflecting the Re-dca 2 induced glycolysis-to-glucose oxidation reversal at the early drug treatment stage. The excellent phosphorescence of Re-dca 2 can also be utilized for real-time tracking of mitochondrial morphological changes during treatment. In a word, rational design of phosphorescent metallodrug and metabolic modulator conjugates for synergistic treatment is a promising strategy for simultaneous untuning and tracking tumor metabolic machine, thus providing new clues for cancer therapy and mechanisms.

Metabolism targeting therapy of dichloroacetate-loaded electrospun mats on colorectal cancer

Natural Product Albiziabioside A Conjugated with Pyruvate Dehydrogenase Kinase Inhibitor Dichloroacetate to Induce Apoptosis-Ferroptosis-M2-TAMs Polarization for Combined Cancer Therapy

Impact of Sodium Dichloroacetate Alone and in Combination Therapies on Lung Tumor Growth and Metastasis

Dichloroacetic Acid Upregulates Apoptosis Of Ovarian Cancer Cells By Regulating Mitochondrial Function

Unraveling the therapeutic mechanisms of dichloroacetic acid in lung cancer through integrated multi-omics approaches: metabolomics and transcriptomics

Superior anti-tumor efficacy of diisopropylamine dichloroacetate compared with dichloroacetate in a subcutaneous transplantation breast tumor model.

Deoxycholic Acid-Modified Microporous Sio2 Nanofibers Mimicking Colorectal Microenvironment To Optimize Radiotherapy-Chemotherapy Combined Therapy

Dichloroacetate shifts the metabolism from glycolysis to glucose oxidation and exhibits synergistic growth inhibition with cisplatin in HeLa cells.

A Biodegradable Nanodrug with Highly Efficient Treatment Effect by Remodeling Tumor Microenvironment and Manipulating Energy Metabolism Against Colorectal Cancer

Impairing Tumor Metabolic Plasticity Via a Stable Metal‐Phenolic Based Polymeric Nanomedicine to Suppress Colorectal Cancer

Targeted Reversal and Phosphorescence Lifetime Imaging of Cancer Cell Metabolism Via a Theranostic Rhenium(i)-Dca Conjugate.

A Sub-6 Nm MnFe2O4-dichloroacetic Acid Nanocomposite Modulates Tumor Metabolism and Catabolism for Reversing Tumor Immunosuppressive Microenvironment and Boosting Immunotherapy.

Dichloroacetate enhances adriamycin-induced hepatoma cell toxicity in vitro and in vivo by increasing reactive oxygen species levels

Dichloroacetate Enhances the Antitumor Efficacy of Chemotherapeutic Agents Via Inhibiting Autophagy in Non-Small-cell Lung Cancer

Antitumor Activity of Dichloroacetate on C6 Glioma Cell: in Vitro and in Vivo Evaluation

Effects of Dichloroacetate on the Activation of the Mitochondrial Pathway in C6 Cells in Vitro

Dichloroacetate as a novel pharmaceutical treatment for cancer-related fatigue in melanoma

Long-term stabilization of stage 4 colon cancer using sodium dichloroacetate therapy

DCA Increases the Antitumor Effects of Capecitabine in a Mouse B16 Melanoma Allograft and a Human Non-Small Cell Lung Cancer A549 Xenograft.

Deoxycholic acid-modified microporous SiO 2 nanofibers mimicking colorectal microenvironment to optimize radiotherapy-chemotherapy combined therapy

Doxorubicin-loaded Polysaccharide Nanoparticles Suppress the Growth of Murine Colorectal Carcinoma and Inhibit the Metastasis of Murine Mammary Carcinoma in Rodent Models.